Hematologic Markers as Prognostic Factors in Nonmetastatic Esophageal Cancer Patients under Concurrent Chemoradiotherapy

Nonmetastatic esophageal cancer can demonstrate a high local recurrence rate even under the standard treatment. We evaluated platelet counts before and after concurrent chemoradiotherapy (CCRT), neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio for predicting esophageal cancer prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yi-Feng, Chu, Sung-Chao, Chang, Bee-Song, Cheng, Yi-Tso, Wang, Tso-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374875/
https://www.ncbi.nlm.nih.gov/pubmed/30834254
http://dx.doi.org/10.1155/2019/1263050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374875/
https://www.ncbi.nlm.nih.gov/pubmed/30834254
http://dx.doi.org/10.1155/2019/1263050

Ejemplares similares